Clinical Trial: Study on the Regulatory Role of TWEAK/Fn14 Signaling Pathway in Proliferation and Induced Differentiation of Hair Follicle Stem Cells (China)

Posted On: 2026-09-15

China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Regulatory Role of TWEAK/Fn14 Signaling Pathway in Proliferation and Induced Differentiation of Hair Follicle Stem Cells'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132368

Registration Time: 2026/09/14

Type: Observational study

Primary Sponsor: The second Affiliated Hospital of Kunming Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333117

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Study on the Regulatory Role of TWEAK/Fn14 Signaling Pathway in Proliferation and Induced Differentiation of Hair Follicle Stem Cells (China)